Author Topic: SPHS - Sophiris Bio  (Read 611 times)


  • Newbie
  • *
  • Posts: 1
SPHS - Sophiris Bio
« on: October 31, 2018, 05:11:37 AM »
Hello all,

I just recently registered for this board. So, I am trying to find my way around this. Pardon me, if SPHS has already been discussed or is being discussed. I am trying to inquire whether anyone holds a position in Sophiris Bio (Nasdaq ticker SPHS)? If so, I am wondering what your thoughts are respective its current share price. I realize that Ph2B final patient results are due late Q4 of 2018. I hold Randall Woods and is staff as very knowledgeable, but am concerned whether dilution may be on the horizon, particularly if he chooses to progress into Phase 3 for PC and possibly into another Phase 3 for BPH? Appreciate any feedback. I own and have been holding a position for nearly 3 years. Thanks again.
« Last Edit: October 31, 2018, 04:09:57 PM by Parsad »